Your browser doesn't support javascript.
loading
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial.
Motzer, Robert J; Robbins, Paul B; Powles, Thomas; Albiges, Laurence; Haanen, John B; Larkin, James; Mu, Xinmeng Jasmine; Ching, Keith A; Uemura, Motohide; Pal, Sumanta K; Alekseev, Boris; Gravis, Gwenaelle; Campbell, Matthew T; Penkov, Konstantin; Lee, Jae Lyun; Hariharan, Subramanian; Wang, Xiao; Zhang, Weidong; Wang, Jing; Chudnovsky, Aleksander; di Pietro, Alessandra; Donahue, Amber C; Choueiri, Toni K.
Afiliação
  • Motzer RJ; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. motzerr@mskcc.org.
  • Robbins PB; Translational Oncology, Pfizer, San Diego, CA, USA.
  • Powles T; Department of Genitourinary Oncology, Barts Cancer Institute, Experimental Cancer Medicine Centre, Queen Mary University of London, St Bartholomew's Hospital, London, UK.
  • Albiges L; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
  • Haanen JB; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Larkin J; Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, London, UK.
  • Mu XJ; Computational Biology, Pfizer, San Diego, CA, USA.
  • Ching KA; Computational Biology, Pfizer, San Diego, CA, USA.
  • Uemura M; Graduate School of Medicine, Osaka University Hospital, Osaka, Japan.
  • Pal SK; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Alekseev B; Deputy Director for Science, Moscow Scientific Research Oncology Institute, Moscow, Russian Federation.
  • Gravis G; Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France.
  • Campbell MT; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Penkov K; Private Medical Institution, Euromedservice, St. Petersburg, Russian Federation.
  • Lee JL; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Hariharan S; Oncology, Pfizer, New York, NY, USA.
  • Wang X; Computational Biology, Pfizer, San Diego, CA, USA.
  • Zhang W; Lyell Immunopharma, South San Francisco, CA, USA.
  • Wang J; Biostatistics, Pfizer, Cambridge, MA, USA.
  • Chudnovsky A; Jounce Therapeutics, Cambridge, MA, USA.
  • di Pietro A; Biostatistics, Pfizer, Cambridge, MA, USA.
  • Donahue AC; Oncology, Pfizer, Cambridge, MA, USA.
  • Choueiri TK; Ipsen, Cambridge, MA, USA.
Nat Med ; 26(11): 1733-1741, 2020 11.
Article em En | MEDLINE | ID: mdl-32895571
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Biomarcadores Tumorais / Anticorpos Monoclonais Humanizados / Sunitinibe / Axitinibe Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Biomarcadores Tumorais / Anticorpos Monoclonais Humanizados / Sunitinibe / Axitinibe Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos